Ask AI
ProCE Banner Activity

PrEPFACTS: Real-world Persistence on LA CAB PrEP in the United States

Conference Coverage
Slideset

In this US study of long-acting cabotegravir PrEP, people with commercial healthcare insurance had the highest 1-year persistence rates, compared with Medicare and Medicaid. Further study is needed to determine drivers of PrEP persistence in real-world settings. 

Released: November 16, 2026

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

This activity is supported by educational grants from Gilead Sciences, Inc. and ViiV Healthcare.

Gilead Sciences, Inc.

ViiV Healthcare

Target Audience

This activity is intended for physicians, pharmacists, registered nurses, and other healthcare professionals who care for people living with or at risk of HIV infection.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Appropriately apply and counsel patients regarding the clinical role(s) of new and investigational ART regimens and strategies

  • Devise HIV management strategies based on the results of recent clinical studies of established antiretroviral agents

  • Integrate the latest scientific findings to develop and optimize effective HIV prevention interventions